Clinical Trials Educational Deck
Overview of foundational knowledge about clinical trials for educational purposes | Slide Deck
Patient Biomarker Brochure
A patient-oriented resource explaining the importance of biomarker testing in non-small cell lung cancer (NSCLC) and the steps that are required to do these tests | Brochure
Merkel Cell Carcinoma Disease Overview
Overview of the disease state and etiology of Merkel cell carcinoma (MCC) | Infographic
NSCLC Disease Overview
Overview of lung cancer statistics, signs and symptoms, and subtypes. More detailed information for the non-small cell lung cancer subtype | Infographic
Healthcare Disparities in Lung Cancer
Overview of healthcare disparities in patients with lung cancer | Slide Deck
Bladder Cancer Overview
Presenting disease background into bladder cancer and a deeper dive on the main type, urothelial carcinoma | Infographic
Healthcare Disparities in Bladder Cancer
Overview of healthcare disparities in patients with bladder cancer | Slide Deck
Biomarker Testing in NSCLC Podcast
Perspectives from US-based Oncologists on the importance of biomarker testing for actionable alterations in non-small cell lung cancer | Podcast
Biomarker Testing in NSCLC Transcript
Accessible transcript of the podcast conversation between two US-based Oncologists on the topic of biomarker testing in non-small cell lung cancer | Podcast
Biomarkers in NSCLC
A presentation of the role of molecular biomarkers, technical considerations and the importance of testing for them in the context of non-small cell lung cancer | Slide Deck
Renal Cell Carcinoma Disease Overview
Educational slide deck presenting information for renal cell carcinoma (RCC) pathogenesis, risk factors, natural history of disease and epidemiology | Slide Deck
Antibody-drug Conjugates Technology
Introducing the technology of antibody drug conjugates (ADCs) and how it can be used as a treatment option in Oncology | Video
DNA Damage Repair Overview
Showcasing the DNA damage repair (DDR) mechanism and how it could be leveraged to deliver potential therapeutics for cancer | Video
Diversity Equity and Inclusion in Clinical Trials
Educational slide deck underlining the importance of DEI initiatives in clinical trial development | Slide Deck
This site is intended for US healthcare professionals only.
DISCLAIMER: This site contains medical information that is intended for healthcare providers of the United States only. The medical information contained on this site is not meant to substitute for the advice provided by a medical professional. Canadian residents should consult the EMD Serono Canada Inc. website at www.emdserono.ca for information on products and services approved in Canada. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy.
EMD Serono is the Healthcare business of Merck KGaA, Darmstadt, Germany, in the United States and Canada.
US-MULNP-00023 09/24
By clicking this link, you are leaving medical.emdserono.com. Please, note that this link will take you to a website on which different Privacy Policy and Conditions may apply. EMD Serono accepts no responsibility for websites not controlled directly by us. Please check Privacy Policy and Conditions of the linked website.
Help us direct you to the right information by selecting one of the following options: